Brittany Lamboy, NP
Nurse Practitioner · Philadelphia, PANPI 1023619970
Payments from drug & device makers
Across 99 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$229
- AbbVie$224
- Regeneron Healthcare Solutions, Inc.$177
- LEO Pharma Inc.$136
- Sun Pharmaceutical Industries Inc.$123
- E.r. Squibb & Sons, L.L.C.$109
- plus $714 from 15 others
What the payments were for
- Food & beverage$1,55191%
- Education$1609%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 14 | $229 |
| AbbVie | 16 | $224 |
| Regeneron Healthcare Solutions, Inc. | 5 | $177 |
| LEO Pharma Inc. | 9 | $136 |
| Sun Pharmaceutical Industries Inc. | 7 | $123 |
| E.r. Squibb & Sons, L.L.C. | 7 | $109 |
| Johnson & Johnson | 6 | $102 |
| Novartis | 5 | $95 |
| Organon | 7 | $75 |
| Incyte Corporation | 4 | $74 |
| Sanofi-aventis U.S. LLC | 1 | $60 |
| Arcutis Biotherapeutics, Inc. | 3 | $49 |
| Sanofi | 2 | $40 |
| Amgen | 2 | $38 |
| Pfizer | 2 | $35 |
| UCB, Inc. | 2 | $34 |
| Galderma Laboratories, L.p. | 2 | $31 |
| Dermavant Sciences, Inc. | 2 | $27 |
| Botanix SB Inc | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $15 |
How this compares
$1,711 in reported general payments places this provider in the 85th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 37 | $136,684 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $101,011 |
| Clobetasol Propionate | 85 | $3,436 |
| Ketoconazole | 148 | $2,504 |
| Tacrolimus | 18 | $2,150 |
| Fluorouracil | 13 | $1,097 |
| Triamcinolone Acetonide | 101 | $957 |
| Clindamycin Phosphate | 17 | $871 |
| Metronidazole | 25 | $655 |
| Ammonium Lactate | 33 | $398 |
| Desonide | 17 | $363 |
| ValacyclovirValacyclovir Hcl | 15 | $216 |
| Doxycycline Hyclate | 22 | $215 |
| Mupirocin | 25 | $205 |
| Hydrocortisone | 36 | $202 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Philadelphia
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Carolyn GrandePhiladelphia$71K
- Faith MutalePhiladelphia$62K
- Frances RogersPhiladelphia$46K
- Meghan GarabedianPhiladelphia$30K
- Victoria SherryPhiladelphia$10K
- Tracey WileyChambersburg$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.